These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6440705)

  • 1. Free valproic acid: steady-state pharmacokinetics in patients with intractable epilepsy.
    Otten N; Hall K; Irvine-Meek J; Leroux M; Budnik D; Seshia S
    Can J Neurol Sci; 1984 Nov; 11(4):457-60. PubMed ID: 6440705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic parameters of total and unbound valproic acid and their relationships to seizure control in epileptic children.
    Panomvana Na Ayudhya D; Suwanmanee J; Visudtibhan A
    Am J Ther; 2006; 13(3):211-7. PubMed ID: 16772762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multivariable analysis of factors governing the steady-state pharmacokinetics of valproic acid in 52 young epileptics.
    Hall K; Otten N; Johnston B; Irvine-Meek J; Leroux M; Seshia S
    J Clin Pharmacol; 1985; 25(4):261-8. PubMed ID: 3924980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of total and free valproic acid during monotherapy in infants.
    Herngren L; Lundberg B; Nergårdh A
    J Neurol; 1991 Sep; 238(6):315-9. PubMed ID: 1940980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms and valproic acid plasma concentration in children with epilepsy on valproic acid monotherapy.
    Mei S; Feng W; Zhu L; Yu Y; Yang W; Gao B; Wu X; Zhao Z; Fang F
    Seizure; 2017 Oct; 51():22-26. PubMed ID: 28763744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A population pharmacokinetic model of valproic acid in pediatric patients with epilepsy: a non-linear pharmacokinetic model based on protein-binding saturation.
    Ding J; Wang Y; Lin W; Wang C; Zhao L; Li X; Zhao Z; Miao L; Jiao Z
    Clin Pharmacokinet; 2015 Mar; 54(3):305-17. PubMed ID: 25388986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproic acid free fraction in epileptic children under chronic monotherapy.
    Riva R; Albani F; Franzoni E; Perucca E; Santucci M; Baruzzi A
    Ther Drug Monit; 1983 Jun; 5(2):197-200. PubMed ID: 6410546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between valproic acid dosage, plasma concentration and clearance in adult monotherapy patients with epilepsy.
    Gidal BE; Pitterle ME; Spencer NW; Maly MM
    J Clin Pharm Ther; 1995 Aug; 20(4):215-9. PubMed ID: 8557785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative clinical and pharmacokinetic study of a new slow-release versus conventional preparations of valproic acid in children with intractable epilepsy.
    Imaizumi T; Izumi T; Fukuyama Y
    Brain Dev; 1992 Sep; 14(5):304-8. PubMed ID: 1456384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of steady-state pharmacokinetics of valproic acid in children between monotherapy and multiple antiepileptic drug treatment.
    Chiba K; Suganuma T; Ishizaki T; Iriki T; Shirai Y; Naitoh H; Hori M
    J Pediatr; 1985 Apr; 106(4):653-8. PubMed ID: 3920375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of age and co-medication on the steady-state pharmacokinetics of valproic acid in Tunisian patients with epilepsy.
    Ben Mahmoud L; Hakim A; Ghozzi H; Atheymen R; Sahnoun Z; Zeghal K
    Rev Neurol (Paris); 2017 Mar; 173(3):159-163. PubMed ID: 28320517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of saliva and serum free valproic acid concentrations in persons with epilepsy.
    Dwivedi R; Gupta YK; Singh M; Joshi R; Tiwari P; Kaleekal T; Tripathi M
    Seizure; 2015 Feb; 25():187-90. PubMed ID: 25455060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the pharmacokinetics of total and free valproate in mono- and bitherapy with carbamazepine in epileptic children and adolescents.
    Steinborn B; Galas-Zgorzalewicz B
    Folia Neuropathol; 2002; 40(2):97-100. PubMed ID: 12230261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproic acid efficacy, toxicity, and pharmacokinetics in neonates with intractable seizures.
    Gal P; Oles KS; Gilman JT; Weaver R
    Neurology; 1988 Mar; 38(3):467-71. PubMed ID: 3126410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between plasma ammonia level and serum trough concentration of free valproic acid in patients with epilepsy.
    Itoh H; Suzuki Y; Fujisaki K; Sato Y; Takeyama M
    Biol Pharm Bull; 2012; 35(6):971-4. PubMed ID: 22687541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the steady-state pharmacokinetics of topiramate and valproate in patients with epilepsy during monotherapy and concomitant therapy.
    Rosenfeld WE; Liao S; Kramer LD; Anderson G; Palmer M; Levy RH; Nayak RK
    Epilepsia; 1997 Mar; 38(3):324-33. PubMed ID: 9070595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring free valproic acid in epilepsy patients medicated with coanticonvulsants.
    Haidukewych D; Rodin EA
    Ther Drug Monit; 1982; 4(2):209-12. PubMed ID: 6808716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No effect of co-administered antiepileptic drugs on in-vivo protein binding parameters of valproic acid in patients with epilepsy.
    Suzuki Y; Itoh H; Abe T; Nishimura F; Sato Y; Takeyama M
    J Pharm Pharmacol; 2011 Jul; 63(7):976-81. PubMed ID: 21635265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased apparent oral clearance of valproic acid during intake of combined contraceptive steroids in women with epilepsy.
    Galimberti CA; Mazzucchelli I; Arbasino C; Canevini MP; Fattore C; Perucca E
    Epilepsia; 2006 Sep; 47(9):1569-72. PubMed ID: 16981874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steady-state valproate pharmacokinetics during long term therapy.
    Eadie MJ; Heazlewood V; McKauge L; Tyrer JH
    Clin Exp Neurol; 1983; 19():183-91. PubMed ID: 6439443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.